Answers are grounded in this paper and cite their sources.
The higher dose 2 reduced PPGE versus the current label recommended dose 1 within the two-hour postprandial timeframe without any new safety concerns. When confirmed with a larger study, this higher TI dosing recommendation may help patients and clinicians minimize immediate postprandial hyperglycemia when titrating TI for prandial glucose control.
No takes yet. Share an insight, caveat, or question.
Kaiserman et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: